1) irbesartan/hydrochlorothiazide combination
厄贝沙坦/氢氯噻嗪
1.
The investigation of the curative effect of irbesartan/hydrochlorothiazide combination on the mild to moderate hypertension patients with left ventricular hypertrophy
厄贝沙坦/氢氯噻嗪治疗轻中度高血压左心室肥厚疗效观察
2) Irbesartan and hydrochlorothiazide
厄贝沙坦氢氯噻嗪
3) Irbesartan and Hydrochlorothiazide Tablets
厄贝沙坦氢氯噻嗪片
1.
Aim To compare the clinical effects of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets in the treatment of hypertension.
目的比较厄贝沙坦片和厄贝沙坦氢氯噻嗪片对轻中度高血压患者的降压疗效。
5) Valsartan/hydrochlorothiazide
缬沙坦/氢氯噻嗪
1.
Comparison of valsartan/hydrochlorothiazide and valsartan in the treatment of hypertension;
缬沙坦/氢氯噻嗪复方制剂和缬沙坦降压疗效的比较
6) valsartan and hydrochlorothiaxide
缬沙坦氢氯噻嗪
1.
Clinical analysis of adverse reaction of 168 patients with valsartan and hydrochlorothiaxide
缬沙坦氢氯噻嗪片不良反应168例临床分析
补充资料:厄贝沙坦
分子式:C25H28N6O
分子量:暂无
CAS号:138402-11-6
性质:暂无
制备方法:暂无
用途:抗高血压药。
分子量:暂无
CAS号:138402-11-6
性质:暂无
制备方法:暂无
用途:抗高血压药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条